These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36858775)
1. Chemical mechanisms of DNA damage by carcinogenic chromium(VI). Krawic C; Zhitkovich A Adv Pharmacol; 2023; 96():25-46. PubMed ID: 36858775 [TBL] [Abstract][Full Text] [Related]
2. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Quievryn G; Peterson E; Messer J; Zhitkovich A Biochemistry; 2003 Feb; 42(4):1062-70. PubMed ID: 12549927 [TBL] [Abstract][Full Text] [Related]
3. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate. Quievryn G; Messer J; Zhitkovich A Carcinogenesis; 2006 Nov; 27(11):2316-21. PubMed ID: 16714765 [TBL] [Abstract][Full Text] [Related]
4. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Zhitkovich A; Quievryn G; Messer J; Motylevich Z Environ Health Perspect; 2002 Oct; 110 Suppl 5(Suppl 5):729-31. PubMed ID: 12426121 [TBL] [Abstract][Full Text] [Related]
5. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Quievryn G; Messer J; Zhitkovich A Biochemistry; 2002 Mar; 41(9):3156-67. PubMed ID: 11863455 [TBL] [Abstract][Full Text] [Related]
6. Undetectable role of oxidative DNA damage in cell cycle, cytotoxic and clastogenic effects of Cr(VI) in human lung cells with restored ascorbate levels. Reynolds M; Armknecht S; Johnston T; Zhitkovich A Mutagenesis; 2012 Jul; 27(4):437-43. PubMed ID: 22241526 [TBL] [Abstract][Full Text] [Related]
7. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates. Quievryn G; Goulart M; Messer J; Zhitkovich A Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591 [TBL] [Abstract][Full Text] [Related]
8. Chromium in drinking water: sources, metabolism, and cancer risks. Zhitkovich A Chem Res Toxicol; 2011 Oct; 24(10):1617-29. PubMed ID: 21766833 [TBL] [Abstract][Full Text] [Related]
10. Chromium(VI) causes interstrand DNA cross-linking in vitro but shows no hypersensitivity in cross-link repair-deficient human cells. Morse JL; Luczak MW; Zhitkovich A Chem Res Toxicol; 2013 Oct; 26(10):1591-8. PubMed ID: 24059640 [TBL] [Abstract][Full Text] [Related]
11. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Reynolds M; Stoddard L; Bespalov I; Zhitkovich A Nucleic Acids Res; 2007; 35(2):465-76. PubMed ID: 17169990 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of Cr(VI) by ascorbate but not glutathione is a low oxidant-generating process. Wong V; Armknecht S; Zhitkovich A J Trace Elem Med Biol; 2012 Jun; 26(2-3):192-6. PubMed ID: 22572042 [TBL] [Abstract][Full Text] [Related]
13. Examining the Potential Formation of Ternary DNA Complexes with Chromium‑Cysteine, Chromium-Ascorbate, and Chromium-Glutathione and Implications for Their Carcinogenicity. Marchi S; Lankford E; Dorin B; Drummond E; Thomas SC; Woski SA; Vincent JB Biol Trace Elem Res; 2023 Oct; 201(10):5053-5066. PubMed ID: 36662348 [TBL] [Abstract][Full Text] [Related]
14. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049 [TBL] [Abstract][Full Text] [Related]
15. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Zhitkovich A; Song Y; Quievryn G; Voitkun V Biochemistry; 2001 Jan; 40(2):549-60. PubMed ID: 11148050 [TBL] [Abstract][Full Text] [Related]
16. Toxicological Antagonism among Welding Fume Metals: Inactivation of Soluble Cr(VI) by Iron. Krawic C; Zhitkovich A Chem Res Toxicol; 2018 Nov; 31(11):1172-1184. PubMed ID: 30362728 [TBL] [Abstract][Full Text] [Related]
17. A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium (VI) by glutathione. Kortenkamp A; Casadevall M; Faux SP; Jenner A; Shayer RO; Woodbridge N; O'Brien P Arch Biochem Biophys; 1996 May; 329(2):199-207. PubMed ID: 8638952 [TBL] [Abstract][Full Text] [Related]
18. Reduction with glutathione is a weakly mutagenic pathway in chromium(VI) metabolism. Guttmann D; Poage G; Johnston T; Zhitkovich A Chem Res Toxicol; 2008 Nov; 21(11):2188-94. PubMed ID: 18808157 [TBL] [Abstract][Full Text] [Related]
19. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by Chromium(VI) reduction with ascorbate. Tsou TC; Lai HJ; Yang JL Chem Res Toxicol; 1999 Oct; 12(10):1002-9. PubMed ID: 10525278 [TBL] [Abstract][Full Text] [Related]
20. In vivo effects of ascorbate and glutathione on the uptake of chromium, formation of chromium(V), chromium-DNA binding and 8-hydroxy-2'-deoxyguanosine in liver and kidney of osteogenic disorder shionogi rats following treatment with chromium(VI). Yuann JM; Liu KJ; Hamilton JW; Wetterhahn KE Carcinogenesis; 1999 Jul; 20(7):1267-75. PubMed ID: 10383900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]